Gene Therapy for Asthma

[1]  K. Jeon,et al.  Thiol-Reactive Metal Compounds Inhibit NF-κB Activation by Blocking IκB Kinase1 , 2000, The Journal of Immunology.

[2]  S. Albelda,et al.  Gene Therapy for Lung Disease: Hype or Hope? , 2000, Annals of Internal Medicine.

[3]  K. Jeon,et al.  Thiol-reactive metal compounds inhibit NF-kappa B activation by blocking I kappa B kinase. , 2000, Journal of immunology.

[4]  H. Yssel,et al.  Characterization of T Cell Subpopulations Involved in the Pathogenesis of Asthma and Allergic Diseases , 2000, International Archives of Allergy and Immunology.

[5]  M. Jordana,et al.  Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice. , 1999, American journal of respiratory cell and molecular biology.

[6]  E. Gelfand,et al.  Systemic and local interferon gamma gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in mice. , 1999, Human gene therapy.

[7]  D. Geddes,et al.  Gene therapy for asthma: inspired research or unnecessary effort? , 1999, Gene Therapy.

[8]  J. Bousquet,et al.  The glucocorticoid receptor gene as a candidate for gene therapy in asthma , 1999, Gene Therapy.

[9]  G. Berry,et al.  Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. , 1999, The Journal of clinical investigation.

[10]  J Bousquet,et al.  Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. , 1998, The Journal of allergy and clinical immunology.

[11]  P. Foster,et al.  Mucosal IL‐12 gene delivery inhibits allergic airways disease and restores local antiviral immunity , 1998, European journal of immunology.

[12]  G. Chrousos,et al.  Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor β , 1997, The Journal of experimental medicine.

[13]  J. Nyce,et al.  DNA antisense therapy for asthma in an animal model , 1997, Nature.

[14]  M. Wills-Karp,et al.  Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. , 1996, Journal of immunology.

[15]  I. Bernstein,et al.  A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial. , 1996, The Journal of allergy and clinical immunology.

[16]  Shau-ku Huang,et al.  Immunoprophylaxis of allergen–induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization , 1996, Nature Medicine.

[17]  E. Raz,et al.  Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Hessel,et al.  Lung inflammation and epithelial changes in a murine model of atopic asthma. , 1996, American journal of respiratory cell and molecular biology.

[19]  F. Bach,et al.  Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B , 1996, The Journal of experimental medicine.

[20]  B. Vargaftig,et al.  In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs. , 1996, The Journal of clinical investigation.

[21]  P. Barnes,et al.  Glucocorticoid resistance in asthma. , 1995, American journal of respiratory and critical care medicine.

[22]  I. Adcock,et al.  Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma , 1995, The Journal of experimental medicine.

[23]  Z. Eshhar,et al.  Specific elimination of IgE production using T cell lines expressing chimeric T cell receptor genes , 1995, European journal of immunology.

[24]  R. Egan,et al.  Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. , 1995, American journal of respiratory cell and molecular biology.

[25]  R. Egan,et al.  Effects of an antibody to interleukin-5 in a monkey model of asthma. , 1995, American journal of respiratory and critical care medicine.

[26]  R. Strieter,et al.  Leukocyte infiltration in allergic airway inflammation. , 1995, American journal of respiratory cell and molecular biology.

[27]  A. deFazio,et al.  Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  I. Adcock,et al.  Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. , 1995, Journal of immunology.

[29]  R. Egan,et al.  Mast cells modulate allergic pulmonary eosinophilia in mice. , 1995, American journal of respiratory cell and molecular biology.

[30]  R. Egan,et al.  T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. , 1995, Clinical immunology and immunopathology.

[31]  R. Moss.  Alternative pharmacotherapies for steroid-dependent asthma. , 1995, Chest.

[32]  R. Pauwels,et al.  Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. , 1995, American journal of respiratory cell and molecular biology.

[33]  H. Rabb,et al.  Role of VLA-4 and LFA-1 in allergen-induced airway hyperresponsiveness and lung inflammation in the rat. , 1995, American journal of respiratory and critical care medicine.

[34]  R. Vile,et al.  Targeted vectors for gene therapy , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  R. Martin,et al.  Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma , 1995, The Journal of experimental medicine.

[36]  M. Jordana,et al.  Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma. , 1994, The European respiratory journal.

[37]  T. Kouzarides,et al.  A C‐terminal domain in FosB, absent in FosB/SF and Fra‐1, which is able to interact with the TATA binding protein, is required for altered cell growth. , 1994, The EMBO journal.

[38]  K. Chung,et al.  Contribution of intercellular-adhesion molecule-1 in allergen-induced airway hyperresponsiveness and inflammation in sensitised brown-Norway rats. , 1994, International archives of allergy and immunology.

[39]  J. Arm,et al.  Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma. , 1994, American journal of respiratory cell and molecular biology.

[40]  J. Martin,et al.  The role of the leukocyte adhesion molecules VLA-4, LFA-1, and Mac-1 in allergic airway responses in the rat. , 1994, American journal of respiratory and critical care medicine.

[41]  P. Howarth,et al.  Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. , 1994, The Journal of clinical investigation.

[42]  E. Gelfand,et al.  Nebulized but not parenteral IFN-gamma decreases IgE production and normalizes airways function in a murine model of allergen sensitization. , 1994, Journal of immunology.

[43]  M. Karol,et al.  Animal models of occupational asthma. , 1994, The European respiratory journal.

[44]  M. Peters,et al.  Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor. , 1994, Journal of immunology.

[45]  C. Benjamin,et al.  Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. , 1994, The Journal of clinical investigation.

[46]  S. Marsters,et al.  Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody. , 1994, Journal of immunology.

[47]  R. de Waal Malefyt,et al.  An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13- induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors , 1993, The Journal of experimental medicine.

[48]  S. Szefler,et al.  Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. , 1993, Journal of immunology.

[49]  S. Durham,et al.  Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. , 1993, The Journal of allergy and clinical immunology.

[50]  M. Strek,et al.  Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2. , 1993, The Journal of clinical investigation.

[51]  J. Westwick,et al.  Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. , 1993, American journal of respiratory cell and molecular biology.

[52]  G. Trinchieri,et al.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.

[53]  K. Takatsu,et al.  CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. , 1992, The American review of respiratory disease.

[54]  W. Smith.  Prostanoid biosynthesis and mechanisms of action. , 1992, The American journal of physiology.

[55]  R. Geha,et al.  Regulation of IgE synthesis in humans. , 1992, Journal of clinical immunology.

[56]  E. Clark,et al.  Soluble forms of CD40 inhibit biologic responses of human B cells. , 1992, Journal of immunology.

[57]  C. Wegner,et al.  The role of intercellular adhesion molecule‐1 in chronic airway inflammation , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[58]  H. Gronemeyer.  Control of transcription activation by steroid hormone receptors , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[59]  P. Gergen,et al.  An economic evaluation of asthma in the United States. , 1992, The New England journal of medicine.

[60]  J. Tsai,et al.  Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. , 1991, The American review of respiratory disease.

[61]  R. Crystal,et al.  Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung. , 1991, The Journal of clinical investigation.

[62]  A. B. Kay,et al.  Asthma and inflammation. , 1991, The Journal of allergy and clinical immunology.

[63]  A J Wardlaw,et al.  Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. , 1991, The Journal of clinical investigation.

[64]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[65]  R. Djukanović,et al.  Mucosal inflammation in asthma. , 1990, The American review of respiratory disease.

[66]  G. Gleich,et al.  Lack of suppression of IgE production by recombinant interferon gamma: a controlled trial in patients with allergic rhinitis. , 1990, The Journal of allergy and clinical immunology.

[67]  R. Geha,et al.  Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. , 1990, The American journal of medicine.

[68]  R. Rothlein,et al.  Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. , 1990, Science.

[69]  D. Baltimore,et al.  A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. , 1989, Genes & development.

[70]  B. Butland,et al.  Changes in asthma prevalence: two surveys 15 years apart. , 1989, Archives of disease in childhood.

[71]  G. Sluder.  Centrosomes and the cell cycle , 1989, Journal of Cell Science.

[72]  J. Bousquet,et al.  Asthma mortality in France. , 1987, The Journal of allergy and clinical immunology.

[73]  A. Woolcock.  Worldwide differences in asthma prevalence and mortality. Why is asthma mortality so low in the USA? , 1986, Chest.

[74]  G. Hunninghake,et al.  Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. , 1986, Chest.

[75]  G. Crompton,et al.  Corticosteroid resistance in chronic asthma. , 1981 .

[76]  J. Gough.  POST MORTEM DIFFERENCES IN “ASTHMA” AND IN CHRONIC BRONCHITIS , 1961, Acta allergologica.

[77]  G. Berry,et al.  CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. , 2000, The Journal of clinical investigation.

[78]  D. Curiel,et al.  Gene therapy approaches for inherited and acquired lung diseases. , 1996, American journal of respiratory cell and molecular biology.

[79]  C. Jefcoate.  P450 Cytochromes and Hormonal Regulation: An Overview , 1996 .

[80]  S. Nourshargh,et al.  Lung eosinophilia is dependent on IL-5 and the adhesion molecules CD18 and VLA-4, in a guinea-pig model. , 1995, Immunology.

[81]  K. Shirato,et al.  In situ expression of the cell adhesion molecules in bronchial tissues from asthmatics with air flow limitation: in vivo evidence of VCAM-1/VLA-4 interaction in selective eosinophil infiltration. , 1995, American journal of respiratory cell and molecular biology.

[82]  S. Szefler,et al.  Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. , 1994, The Journal of clinical investigation.

[83]  E. Gelfand,et al.  Steroid-resistant asthma: immunologic and pharmacologic features. , 1992, The Journal of allergy and clinical immunology.

[84]  T. Lee,et al.  Effects of corticosteroids on cytokine generation and expression of activation antigens by monocytes in bronchial asthma. , 1991, International archives of allergy and applied immunology.

[85]  E A Zerhouni,et al.  In vivo measurements of airway reactivity using high-resolution computed tomography. , 1991, The American review of respiratory disease.

[86]  C. Maliszewski,et al.  Soluble receptors for IL-1 and IL-4: biological activity and therapeutic potential. , 1990, Trends in biotechnology.